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ABSTRACT 
Prosopis cineraria (L.) Druce (Le-
guminosae) (syn. Prosopis 
spicigera L.) has antidiabetic and 
antioxidant potential. Earlier we 
reported its hypolipidemic activity 
obtained from ethanol extract (ET-
PCF). Object of this work was to 
isolate ferulic acid (FA) from ET-
PCF and evaluate hypolipidemic 
activity against high-fat diet 
(HFD)-induced hyperlipidemic la-
boratory rats. ET-PCF was sub-
jected to flash column chromatog-
raphy to isolate FA. The chemical 
structure of the isolated compound 
was elucidated by UV, IR, 1H 
NMR,13C NMR and LC-MS. Fur-
ther, the antihyperlipidemic effect 
of FA (10, 20 and 40 mg/kg, p.o.) 
in HFD-induced hyperlipidemic 
rats was investigated. Hyper-
lipidemia was induced in male 
Sprague-Dawley rats by feeding 
with HFD for 60 days. Lipid pa-
rameters such as total cholesterol 
(TC), Low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol (HDL-C) and triglycer-
ides (TG) levels were measured in serum and hepatic tissue. Hepatic oxido-nitrosative stress (SOD, GSH, MDA 
and NO) were also determined. Histological evaluation of liver tissue was carried out. The structure of the isolat-
ed compound was characterized based on spectral data and confirmed as FA. HFD induced an alteration in 
serum, and hepatic lipid profile (triglyceride, cholesterol, HDL, and LDL) was significantly restored (p < 0.001) 
by administration of FA (20 and 40 mg/kg, p.o.). The elevated level of oxido-nitrosative stress in liver was sig-
nificantly reduced (p < 0.001) by FA (20 and 40 mg/kg, p.o.). Histological aberration induced in the liver after 
HFD ingestion were restored by FA administration. Ferulic acid isolated from ET-PCF showed hypolipidemic 
effects in HFD-induced hyperlipidemic rats via modulation of elevated oxido-nitrosative stress. 
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INTRODUCTION 
Maladies of the cardiovascular system 
are a prominent health hazard often leading 
to death. Sedentary lifestyle and erroneous 
food habits encompassing consumption of 
fats and refined sugars lead to a decrease in 
the activity of myosin and actin filaments 
(Brai et al., 2007) accentuate the risk of hy-
perlipidemia, a noteworthy risk factor for 
well-known cardiovascular disorders, athero-
sclerosis, and allied cardiovascular complex-
ities. Around 17.5 million people have died 
due to cardiovascular disease (CVD) repre-
senting 31 % of all global deaths and it is 
expected to grow to more than 23.6 million 
by 2030 (Mozaffarian et al., 2016). The 
proportion of hypertensive individuals in In-
dia is anticipated to expand 2-fold by 2025 
(Brai et al., 2007). The ischemic coronary 
disease is a noteworthy risk factor in the 
pathogenesis of preoperative adverse cardio-
vascular events which enhance the risk of 
mortality in a high-risk surgical patient sub-
population (Howard-Alpe et al., 2006). 
Patient’s cholesterol profile plays a deci-
sive role in the treatment of hyperlipidemia. 
Numerous antihyperlipidemic moieties in-
cluding statins, fibrates, niacin, bile acids, 
ezitimibe, etc. decrease cholesterol levels al-
beit by a different mechanism (Durrington, 
2003). At present, available hypolipidemic 
medications provide relief in a fraction of pa-
tients and have been associated with an array 
of side effects including hyperuricemia, diar-
rhea, nausea, myositis, gastric aggravation, 
flushing, dry skin and altered liver function 
(Santharam et al., 2015). 
For the treatment of various diseases 
such as metabolic syndrome, diabetes, and 
cancer, various plant containing polyphenols 
have been widely used as a potential source 
of treatment (Williamson and Manach, 
2005). Ferulic acid (4-hydroxy-3-metoxy-
benzene acrylic acid), a natural polyphenolic 
compound, is derived from a wide variety of 
plants such as tomato, citrus fruits, carrot, 
sweet corn, cabbage, broccoli, bananas and 
rice bran (Zhao and Moghadasian, 2008). 
Moreover, cell wall of cereal grains and a 
variety of food plants (pineapple, bananas, 
spinach, and beetroot) contain extractable 
amount (0.5-2 %) of FA, and flax seed 
contains the highest concentration of ferulic 
acid glucoside (4.1 ± 0.2 g/kg) (Besseau et 
al., 2007; Kumar and Pruthi, 2014). FA is 
relatively easily and well absorbed when 
compared to other flavonoid compounds 
(Bourne et al., 2000). It has been reported 
that ferulic acid (FA) has a vital cytoprotec-
tive role and proficiently neutralize the onset 
and propagation of a wide cluster of diseas-
es, especially of neurodegenerative organs 
(Mancuso et al., 2007). FA has been reported 
to have anticancer, antihyperlipidemic, 
antihypertensive, antimicrobial, antiviral, 
radioprotective, cardioprotective, antidia-
betic, anti-inflammatory, antiulcer and hepa-
toprotective potential (Baskaran et al., 2010; 
Choi et al., 2011; Liu et al., 2012; Mari-
muthu et al., 2013; Prasad et al., 2006). It has 
been reported that FA acts as a β-secretase 
modulator with therapeutic potential against 
Alzheimer’s disease (Mori et al., 2013). It is 
a potent scavenger of hydroxyl and peroxyl 
radicals in brain cells and macrophages, a 
property that could be responsible for its de-
fensive capacity (Kim et al., 2004; Ogiwara 
et al., 2002). FA promptly frames a reso-
nance-stabilized phenoxy radical, which re-
presents its potent antioxidant activity 
(Kikuzaki et al., 2002; Ogiwara et al., 2002). 
Of late, a few experimental animal mod-
els of hyperlipidemia have been developed to 
characterize distinctive segments of the 
pathophysiological forms that portray this 
disease. In the present study, hyperlipidemia 
in rats was induced by administration of 
HFD over a period of 60 days. It has been 
proven that HFD caused a significant eleva-
tion in HDL-C in clinical as well as 
preclinical studies (Katan et al., 1994; Nevin 
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and Rajamohan, 2009). The previous study 
carried out in our laboratory found that the 
ethanol extract of Prosopis cineraria (L.) 
Druce (Leguminosae) (syn. Prosopis spici-
gera L.) possesses potent anti-hyperlipid-
emic action against high-fat-diet-induced 
hyperlipidemia in laboratory rat (Jain and 
Surana, 2016). However, purification, stand-
ardization and anti-hyperlipidemic activity 
evaluation of ethanol extract of P. cineraria 
(ET-PCF) is not yet reported. Therefore, the 
present study was undertaken with an objec-
tive of isolation and characterization of ET-
PCF and its evaluation for antihyperlipid-
emic effect on experimental laboratory rats. 
 
MATERIALS AND METHODS 
Drugs and chemicals 
Various drugs and chemicals were 
obtained from a commercially available 
manufacturer such as HFD (60 kcal % fat, 
# D12492, 5.24 kcal/g, Research Diet Inc., 
New Brunswick, NJ, USA). Cholesterol, tri-
glyceride, HDL-C and LDL-C kits (Accurex 
Biomedical Pvt. Ltd., Mumbai, India), Petro-
leum ether (60:80) and diethyl ether (Merck, 
India).  
 
Collection of plant material 
The fresh fruits of the plant P. cineraria 
were collected from Satpuda region of Ma-
harashtra, India. Professor L. K. Kshirsagar 
(Taxonomist, Department of botany, 
S.S.V.P.S’s L. K. Dr. Ghogre Science Col-
lege, Dhule, North Maharashtra University, 
Jalgaon) was authenticating the plant.  
A specimen of the same has been 
submitted to the herbarium of the division. 
 
Preparation of ethanol extract and isolation 
Preparation of ethanol extract of P. cine-
raria fruit was carried out according to the 
previously reported method (Jain and 
Surana, 2015). Briefly, cleaned fruits of P. 
cineraria were cut into small pieces and 
shade dried. Then it crushed in a grinder and 
pulverized into fine powder. This powdered 
material (500 g) was passed through 40 
meshes and macerated with 70 % ethanol us-
ing Soxhlet extractor. The ethanol extract of 
P. cineraria fruits (ET-PCF) was concen-
trated in vacuum evaporator below 40 °C. 
The yield obtained was 12.2 % w/w, and it 
was used for isolation of FA. 50 gram of ET-
PCF was poured on the top of the column 
packed with silica gel. Elution mixture of 
isoamyl alcohol:acetic acid:water (1:1:2) to 
afford a light yellow color solid compound 
(1.34 g). It was recrystallized from hexane to 
yield 0.68 g of product. Thin layer chroma-
tography of ET-PCF in isoamyl alco-
hol:acetic acid:water (1:1:2) showed the 
presence of yellowish green colored single 
spot (Rf 0.88). The remaining fruit powder 
was soaked in ethanol for another six days. 
The solution was filtered, and the combined 
filtrates were concentrated using a rotary 
evaporator to yield 60.3 g of a brown oily 
bark ethanol extract. This ET-PCF under-
went silica gel flash column chromatography 
(Merck 1.07747) using 10 % polarity 
increments from 90:10, chloroform:ethanol 
to 100 % ethanol whereby 100 mL fractions 
were collected. The flash column chromatog-
raphy fractions 5, 6 and 7 were combined 
(2.7 g) and subjected to radial chromatog-
raphy to produce five fractions. The com-
bined fractions 1, 2 and 3 were fractionated 
over silica gel (Merck 1.07749) on prepara-
tive thin layer chromatography to give 54 mg 
of product. 
 
Chemical characterization of isolated  
molecule 
The technique such as UV, IR, 1H NMR, 
13C NMR and LC-MS were used to deter-
mine the chemical structure of the isolated 
compound. IR spectrum was recorded using 
KBr pellets on a Perkin-Elmer IR spectrome-
ter (Perkin-Elmer, Waltham, MA). 1H NMR 
and 13C NMR spectra were recorded using 
CDCl3 as solvent on Bruker Advance II 400 
NMR and LC‐MS spectra were recorded at 
high resolution on a mass spectrometer (Per-
kin Elmer Auto system) at spectrometer 
SAIF Panjab University, Chandigarh, the da-
ta are given in m/z values. 
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Experimental animals 
Male Sprague-Dawley rats (180-220 g) 
were obtained from college animal house of 
R. C. Patel Institute of Pharmaceutical Edu-
cation and Research, Shirpur, India. They 
were housed in well-ventilated cages and 
maintained at a controlled temperature of 22 
± 2 °C with a 12 h light/dark cycle and 
standard lab control. The animals had free 
access to standard pellet chow (Pranav Agro-
Industries Ltd., Sangli, India) and filtered 
water ad libitum throughout the experimental 
protocol. Institutional Animal Ethical Com-
mittee of RCPIPER College, Shirpur ap-
proved the study protocol (IAEC/RCPIPER/ 
2012-13/09). 
 
Development of high-fat diet fed rats 
The two dietary regimes such as normal 
pellet diet (NPD) and high-fat diet (HFD, 
58 % fat, 25 % protein, and 17 % carbohy-
drate, as a percentage of total kcal, ad libi-
tum) were fed to rats for the initial period of 
60 days. The composition and preparation of 
HFD as were described elsewhere (Jain and 
Surana, 2016).  
 
Experimental design 
The studies were conducted in the fol-
lowing groups of animals 
Group I: Normal rats: rats received normal 
pellet diet, and they were treated 
with vehicle (10 mg/kg of dis-
tilled water) 
Group II: HFD control: rats received high-
fat diet, and they were treated 
with vehicle (10 mg/kg of dis-
tilled water) 
Group III: AT (1.2): rats received high-fat 
diet, and they were treated with 
atorvastatin (1.2 mg/kg)  
Group IV: FA (10): rats received high-fat 
diet, and they were treated with 
ferulic acid (10 mg/kg) 
Group V: FA (20): rats received high-fat 
diet, and they were treated with 
ferulic acid (20 mg/kg) 
Group VI: FA (40): rats received high-fat 
diet, and they were treated with 
ferulic acid (40 mg/kg). 
The dose of FA (10, 20 and 40 mg/kg, 
p.o.) was selected on the basis of a previous-
ly reported method (Balasubashini et al., 
2004). Vehicle or atorvastatin or FA was 
administered orally for 60 consecutive days. 
After the end of treatment, rats fasted 
overnight and, after 24 h, they were 
sequentially anesthetized with anesthetic 
ether for about 30-40 s. The blood was 
withdrawn by retro-orbital puncture. Each 
blood sample was collected into separate vi-
als for the determination of serum parame-
ters. 
 
Preparation of serum samples and  
biochemical estimations 
The serum was separated by centrifuga-
tion using an Eppendorf cryocentrifuge 
(model no. 5810, Eppendorf, Hamburg, 
Germany), maintained at 4 °C and run at a 
speed of 7000 rpm for 15 min. The levels of 
high-density lipoprotein (HDL), low-density 
lipoprotein (LDL), triglyceride (TG) and 
Total cholesterol (TC) were measured by a 
spectrophotometer (UV-visible spectro-
photometer, Jasco V-530, Tokyo, Japan) 
using commercially available reagent kits 
according to procedure provided by 
manufacturer (Accurex Biomedical Pvt. Ltd., 
Mumbai, India) (Adil et al., 2015; Honmore 
et al., 2015). 
 
Preparation of liver homogenates 
After the blood collection, the animal 
was sacrificed by cervical dislocation and the 
liver was removed and immediately homog-
enized in 3 mL of ice-cold PBS buffer. One 
portion of the supernatant was utilized for 
subsequent measurement of SOD, GSH, 
MDA and NO according to earlier reported 
methods (Adil et al., 2015; Honmore et al., 
2015). The remaining portion of the liver su-
pernatant was utilized for subsequent meas-
urement of HDL, LDL, TG and Total choles-
terol by using commercially available rea-
gent kits according to the procedure provided 
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by the manufacturer (Accurex Biomedical 
Pvt. Ltd., Mumbai, India). One liver tissue 
from each group was processed for histo-
pathological examination. 
 
Liver tissue histopathology 
Liver tissue was fixed in 10 % (v/v) neu-
tral buffered formalin for 24 h for histo-
pathological studies. It was processed for 
12 h using isopropyl alcohol, xylene, and 
paraffin embedded for light microscopic 
study (Nikon E200, Japan). Paraffin-
embedded tissue sections cut at 5 μm thick-
ness were prepared and stained after deparaf-
fination using hematoxylin and eosin stain 
(H & E) to verify morphological assessment. 
Photomicrographs were captured at a magni-
fication of 40X. 
 
Statistical analysis 
All statistical analysis was performed us-
ing GraphPad Prism 6.0 (GraphPad Soft-
ware, Inc, La Jolla, CA, USA). Data of body 
weight and biochemical measurements was 
analyzed by separate One-way ANOVA fol-
lowed by Dunnett’s test separately for each 
parameter. A value of p < 0.05 was consid-
ered to be statistically significant. 
 
RESULTS 
Characterization of ferulic acid by IR, 
1H NMR, 13C NMR and LC-MS 
The chemical structure of the isolated 
compound was elucidated by infra-red spec-
troscopy (IR), proton nuclear magnetic reso-
nance (1H NMR), carbon nuclear magnetic 
resonance (13C NMR), and Liquid chroma-
tography-mass spectrometry (LC-MS) exper-
iment. The characterization of isolated com-
pound was carried out by using FT-IR, 1H 
NMR (Figure 1A), 13C NMR (Figure 1B) 
and LC-MS spectra (Figure 2). This charac-
terization results suggested that the isolated 
compound consists of a single chemical moi-
ety with 93 % purity. The isolated compound 
obtained was crystalline light yellow color 
solid (melting point 168 °C to 172 °C).  
In its LC-MS, the molecular ion peak 
M+1 peak at m/z. 195.42 suggesting one of 
the possible molecular formula as C10H10O4. 
Its IR spectrum showed a characteristic 
broad absorption band at 3438 cm-1 for the 
hydroxyl group, it further showed broad 
peaks at 2968 cm-1 for the carboxylic acid 
group, 1691 cm-1 for the carbonyl group and 
1275 cm-1 for the C-O group.  
Its 13C NMR spectrum showed 10 signals 
for 10 carbon signals in the following form: 
(a) nine CH, (b) one CH3. 
The 1H NMR spectrum further showed 
the presence of three methyl groups at  3.9 
s, (3H, J¼5.0, 10.0 Hz), 6.2 d, (1H, J¼7.0, 
10.0 Hz) of CH, 6.8 d, (1H, CH of ar. ring), 
6.9 d, (1H, CH of ar. ring), 7.1 s, (1H, CH), 
7.5 d, (1H, CH) and 9.2 s, (1H, OH) for 
hydroxyl group. From the NMR and LC-MS 
data, the structure of the compound was con-
firmed to be ferulic acid (Singh et al., 2013) 
with purity of 93 %.  
 
Effect of ferulic acid on HFD-induced  
alteration in body weight and liver weight 
of rats 
The body weight and liver weight was sig-
nificant increased (p < 0.001) in the HFD 
control rats as compared to the normal group 
(Table 1). However, increased body weight 
and liver weight was significantly decreased 
(p < 0.001) by FA (20 and 40 mg/kg) treat-
ment as compared to HFD control rats (Ta-
ble 1). Atorvastatin (1.2 mg/kg) treatment al-
so produces a significant decrease (p < 
0.001) in body weight as well as liver weight 
when compared to HFD control rats. Moreo-
ver, body weight and liver weight was more 
significantly decreased (p < 0.05) by treat-
ment with FA (40 mg/kg) treatment as com-
pared to atorvastatin (1.2 mg/kg) treatment 
(Table 1). 
 
Effect of ferulic acid on HFD-induced  
alteration in serum lipid profile and  
atherogenic index of rats 
Administration of HFD significantly 
increases (p < 0.001) the serum triglyceride, 
cholesterol, LDL-C, VLDL-C, LDL to HDL 
ratio and atherogenic index in the HFD con-
trol rats as compared to normal rats (Table 
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1). Administration of FA (10, 20 and 
40 mg/kg) caused a significant and dose-
dependent decrease (p < 0.01, p < 0.001 and 
p < 0.001) in serum triglyceride, cholesterol, 
LDL-C, LDL to HDL ratio and atherogenic 
index as compared to HFD control group 
(Table 1).  
 
 
 
 
 
Figure 1:1H NMR spectrum of ferulic acid (A) and 13C NMR spectrum of ferulic acid (B) were recorded 
using CDCl3 as a solvent on Bruker Advance II 400 NMR. 1H NMR spectrum showed the presence of 
three methyl groups at  3.9 s, (3H, J¼5.0, 10.0 Hz), 6.2 d, (1H, J¼7.0, 10.0 Hz) of CH, 6.8 d, (1H, CH 
of ar. ring), 6.9 d, (1H, CH of ar. ring), 7.1 s, (1H, CH), 7.5 d, (1H, CH) and 9.2 s, (1H, OH) for hydroxyl 
group, whereas 13C NMR spectrum showed 10 signals for 10 carbon signals. 
 
 
 
Figure 2: LC-MS spectrum of ferulic acid showed the molecular ion peak M+1 peak at m/z. 195.42 
suggesting one of the possible molecular formula as C10H10O4. 
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Table 1: Effect of ferulic acid on HFD-induced alteration in body weight, liver weight, serum lipid profile and atherogenic index of rats 
Treatment 
(mg/kg) 
Body weight 
(gm) 
Liver weight 
(gm) 
Triglyceride 
(mg %) 
Cholesterol 
(mg %) 
HDL-C  
(mg %) 
LDL-C  
(mg %) 
VLDL-C  
(mg %) LDL:HDL 
Atherogenic 
index 
normal 234.8 ± 4.79 5.24 ± 0.25 81.9 ± 4.34 71.42 ± 3.65 60.49 ± 2.1 27.34 ± 2.13 16.38 ± 0.87 0.46 ± 0.04 0.18 ± 0.05 
HFD Control 350.8 ± 6.86### 8.98 ± 0.23
### 327.1 ± 
18.6### 
168.9 ± 
5.29### 43.4 ± 2.4
### 64.99 ± 2.17### 
65.42 ± 
3.72### 1.53 ± 0.11
### 2.94 ± 0.2### 
AT (1.2) 276.3 ± 11.77***,$$$ 
6.09 ± 
0.41***,$$$ 
131.2 ± 
8.742***,$$$ 
88.64 ± 
4.32***,$$$ 
56.21 ± 
2.19***,$$$ 
34.43 ± 
3.39***,$$$ 
26.25 ± 
1.75***,$$$ 
0.61 ± 
0.05***,$$$ 
0.59 ± 
0.11***,$$$ 
FA (10) 327.8 ± 11.58 7.85 ± 0.36* 242.9 ± 24.13** 
128.6 ± 
7.74*** 50.97 ± 2.17 50.29 ± 2.52** 48.57 ± 4.83** 1.01 ± 0.09*** 1.53 ± 0.13*** 
FA (20) 283.2 ± 15.35***,$ 7.05 ± 0.22***
203.3 ± 
21.88***,$$ 
111.7 ± 
8.96***,$$ 
56.12 ± 
2.21**,$$ 
41.52 ± 
1.46***,$$ 
40.67 ± 
4.38***,$$ 
0.74 ± 
0.02***,$$ 
1.02 ± 
0.22***,$$ 
FA (40) 250.5 ± 8.74***,$$$ 
5.63 ± 
0.26***,$$$ 
165.5 ± 
10.16***,$$$ 
96 ± 
6.11***,$$$ 
57.38 ± 
2.1***,$$$ 
31.64 ± 
3.24***,$$$ 
33.1 ± 
2.03***,$$$ 
0.55 ± 
0.05***,$$$ 
0.69 ± 
0.13***,$$$ 
Data are expressed as Mean ± SEM and analyzed by One-Way ANOVA followed by Dunnett's post tests. ###p < 0.001 as compared with normal group, *p < 0.05, **p < 0.01, ***p < 0.001 as com-
pared with HFD control group and $p < 0.05, $$p < 0.01, $$$p < 0.001 as compared with each other. HFD: High Fat Diet, AT (1.2): atorvastatin (1.2 mg/kg, p.o.) treated, FA (10): Ferulic acid (10 
mg/kg) treated rats, FA (20): Ferulic acid (20 mg/kg) treated rats and FA (40): Ferulic acid (40 mg/kg) treated rats (n = 6) 
 
Table 2: Effect of ferulic acid on HFD-induced alteration in hepatic serum lipid profile and atherogenic index of rats 
Treatment 
(mg/kg) 
Triglyceride  
(mg %) 
Cholesterol  
(mg %) 
HDL-C  
(mg %) 
LDL-C  
(mg %) 
VLDL-C  
(mg %) LDL:HDL 
Atherogenic  
index 
normal 42.15 ± 3.58 45.01 ± 6.82 29.61 ± 2.05 29.49 ± 2.17 8.43 ± 0.72 1.03 ± 0.13 0.8 ± 0.3 
HFD Control 139.8 ± 8.99### 216.3 ± 10.4### 5.92 ± 0.63### 65.33 ± 4.09### 27.97 ± 1.8### 11.87 ± 1.61### 37.69 ± 4.38### 
AT (1.2) 57.92 ± 7.95***,$$$ 106.6 ± 10.96***,$$$ 27.09 ± 1.91***,$$$ 35.8 ± 2.41***,$$$ 11.58 ± 1.59***,$$$ 1.36 ± 0.13***,$$$ 3.08 ± 0.62***,$$$ 
FA (10) 117.7 ± 7.84 198.3 ± 8.787 13.4 ± 1.72* 57.8 ± 3.83 23.53 ± 1.57 4.83 ± 0.88*** 14.89 ± 1.72*** 
FA (20) 105 ± 5.98**,$$ 129 ± 7.28***,$$ 18.64 ± 1.93***,$$ 50.98 ± 5.00*,$ 21.00 ± 1.2** 2.81 ± 0.27***,$$ 6.37 ± 0.9***,$$$ 
FA (40) 79.73 ± 8.19***,$$$ 83.94 ± 11.65***,$$$ 22.14 ± 1.93***,$$$ 39.92 ± 4.12***,$$$ 15.95 ± 1.64***,$$$ 1.96 ± 0.38***,$$$ 3.08 ± 0.86***,$$$ 
Data are expressed as Mean ± SEM and analyzed by One-Way ANOVA followed by Dunnett's post tests. ###p < 0.001 as compared with normal group, *p < 0.05, **p < 0.01, ***p < 0.001 as com-
pared with HFD control group and $p < 0.05, $$p < 0.01, $$$p < 0.001 as compared with each other. HFD: High Fat Diet, AT (1.2): atorvastatin (1.2 mg/kg, p.o.) treated, FA (10): Ferulic acid (10 
mg/kg) treated rats, FA (20): Ferulic acid (20 mg/kg) treated rats and FA (40): Ferulic acid (40 mg/kg) treated rats (n = 6) 
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There was a significant decrease (p < 
0.001) in the serum HDL-C of HFD control 
group when compared to normal control 
group (Table 1). Treatment with FA (20 and 
40 mg/kg) significantly and dose-
dependently inhibited (p < 0.01 and p < 
0.001) HFD-induced decreased serum HDL-
C as compared to HFD control group (Table 
1). When compared with HFD control group, 
atorvastatin (1.2 mg/kg) treatment also pro-
duced a significant inhibition (p < 0.001) in 
the HFD induced alteration in serum triglyc-
eride, cholesterol, HDL-C, LDL-C, LDL to 
HDL ratio and atherogenic index as com-
pared to HFD control group. Moreover, se-
rum LDL-C level and LDL to HDL ratio was 
more significantly decreased (p < 0.05) by 
FA (40 mg/kg) treatment as compared to 
atorvastatin (1.2 mg/kg) treatment (Table 1). 
 
Effect of ferulic acid on HFD-induced  
alteration in hepatic lipid profile and  
atherogenic index of rats 
HFD control rats exhibits a significantly 
increased (p < 0.001) hepatic triglyceride, 
cholesterol, LDL-C, VLDL-C, LDL to HDL 
ratio and atherogenic index whereas HDL-C 
level in liver was decreased significantly 
(p < 0.001) as compared to normal rats  
(Table 2). Administration of FA (20 and 
40 mg/kg) resulted in a significant inhibi-
tion(p < 0.05) in HFD induced alterations in 
hepatic triglyceride, cholesterol, HDL-C, 
LDL-C, VLDL-C, LDL to HDL ratio and 
atherogenic index (Table 2). Atorvastatin 
(1.2 mg/kg) treatment also produced a signif-
icant inhibition (p < 0.001) in the HFD-
induced alterations in hepatic triglyceride, 
cholesterol, HDL-C, LDL-C, VLDL-C, LDL 
to HDL ratio and atherogenic index as com-
pared to HFD control group. Furthermore, 
FA (40 mg/kg) treatment more significantly 
decreased (p < 0.05) the level of hepatic 
cholesterol as compared to atorvastatin (1.2 
mg/kg) treatment (Table 2). 
 
Effect of ferulic acid on HFD-induced  
alteration in hepatic SOD, GSH, MDA  
and NO levels of rats 
There was a significant decrease (p < 
0.001) in the hepatic SOD and GSH level 
whereas MDA and NO levels in liver were 
increased significantly (p < 0.001) in HFD 
control group as compared to normal group 
(Figure 3). Treatment with FA (20 and 40 
mg/kg) significantly increased (p < 0.001) 
hepatic SOD and GSH levels as compared to 
HFD control rats (Figure 3). Administration 
of atorvastatin (1.2 mg/kg) also produced a 
significant increase (p < 0.001) in hepatic 
SOD and GSH levels as compared to HFD 
control rats. Furthermore, FA (40 mg/kg) 
treatment more significantly increased (p < 
0.05) the level of hepatic SOD level as com-
pared to atorvastatin (1.2 mg/kg) treatment 
(Figure 3).  
Administration of FA (20 and 40 mg/kg) 
significantly inhibited (p < 0.001) HFD-
induced increase in hepatic MDA and NO 
levels as compared to HFD control rats. 
Treatment with atorvastatin (1.2 mg/kg) also 
resulted in a significant decrease (p < 0.001) 
in hepatic MDA and NO levels when com-
pared with HFD control rats. Moreover, he-
patic MDA level was more significantly de-
creased (p < 0.05) by FA (40 mg/kg) treat-
ment as compared to atorvastatin 
(1.2 mg/kg) treatment (Figure 3). 
 
Effect of ferulic acid on HFD-induced  
alteration in rat liver histology 
Hepatic tissue from normal rats exhibited 
normal central vein in liver parenchymal 
cells, without any signs of inflammation and 
necrosis (Figure 4A and Table 3). However, 
it is evident with passive congestion (grade 
1) (which may be due to mild dilatation of 
central veins) and vacuolization (grade 1). 
The histopathological examination of the 
liver of HFD control rats reflected a presence 
of inflammatory cells (black arrow, grade 3) 
with the presence of vesicular fat (grade 3). 
Chronic administration of HFD caused hepa-
tocellular injury reflected by the presence of 
diffuse cytoplasmic vacuolization (grade 3), 
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centrilobular necrosis (red arrow, grade 3), 
vascular congestion and edema (yellow 
arrow, grade 2), and nuclear pyknosis (grade 
2) of the hepatocytes (Figure 4B and Table 
3). However, atorvastatin (1.2 mg/kg) treat-
ment resulted in mild histopathological 
changes in liver marked by vesicular fat 
(grade 1), vacuolization (grade 1), and its 
devoid of any inflammatory cells infiltration 
as well as necrosis, congestion, and edema 
(Figure 4C and Table 3). In the FA (10 and 
20 mg/kg) treated rats, the histology of liver 
exhibited a moderate degree of vacuolization 
(grade 2), necrosis (red arrow, grade 2), ve-
sicular fat (grade 2), congestion and edema 
(yellow arrow, grade 2) around central vein. 
Moderate to mild inflammatory cells 
(black arrow, grade 2) were present in FA 
(10 and 20 mg/kg) treated rats (Figure 4D 
and Figure 4E, respectively and Table 3). 
Liver tissue from FA (40 mg/kg) treated rat 
reflected the presence of inflammatory cells 
infiltration (black arrow, grade 1), vacuoliza-
tion (grade 1) and its devoid of any vesicular 
fat deposition as well as necrosis, congestion 
and edema (Figure 4F and Table 3). 
 
DISCUSSION 
Ferulic acid (FA) is a phenolic com-
pound and a major constituent of an array of 
fruits, vegetables, beverages, and grains. FA 
serves as a scavenger of hydroxyl and per-
oxyl radicals that account for its protective 
function. Previously, the ethanol extract of 
P. cineraria showed potent anti-hyper-
lipidemic action against high-fat-diet-in-
duced hyperlipidemia in laboratory rat (Jain 
and Surana, 2016). However, phytoconstitu-
ents responsible for its antihyperlipidemic 
potential is not yet evaluated. It has been re-
ported that FA is insoluble in water at room 
temperature but it is soluble in hot water, 
ethyl acetate, ethanol and ethyl ether, and it 
has been found that ethanol (60 %) is suita-
ble for the successful extraction of FA (Guo 
et al., 2003). Furthermore, approximately 
80 % of the ferulic acid was found in the
 
 
 
Figure 3: Effect of ferulic acid on HFD-induced alteration in hepatic superoxide dismutase (SOD) (A), 
Glutathione (GSH) (B), Malondialdehyde (MDA), and (C) Nitric oxide (NO) of rats  
Data are expressed as Mean ± SEM and analyzed by One-Way ANOVA followed by Dunnett's post-tests. ###p < 0.001 as com-
pared with normal group, *p < 0.05, ***p < 0.001 as compared with HFD control group and $p < 0.05, $$p < 0.01, $$$p < 0.001 as 
compared with ferulic acid treated group. HFD: High Fat Diet, AT (1.2): atorvastatin (1.2 mg/kg, p.o.) treated, FA (10): Ferulic 
acid (10 mg/kg) treated rats, FA (20): Ferulic acid (20 mg/kg) treated rats and FA (40): Ferulic acid (40 mg/kg) treated rats (n = 
6) 
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Figure 4: Effect of ferulic acid on HFD-induced alteration in rat liver. Representative photographs of rat liver from each group viz., normal (A), High Fat Diet 
control (B), Atorvastatin (1.2 mg/kg, p.o.) treated (C), Ferulic acid (10 mg/kg) treated rats (D), Ferulic acid (20 mg/kg) treated rats (E) and Ferulic acid (40 
mg/kg) treated rats, (F) necrosis (red arrow), inflammatory infiltration (black arrow) and edema (yellow arrow). H&E staining at 40X and 100X (inset) 
 
 
Table 3: Effect of ferulic acid on HFD-induced alteration in rat liver 
Treatment Vesicular fat Inflammatory infiltration Plasma cells Congestion Edema Vacuolization Pyknosis Necrosis 
normal 0 0 0 + 0 + 0 0 
HFD Control +++ +++ +++ ++ ++ +++ ++ +++ 
AT (1.2) + 0 0 0 0 + 0 0 
FA (10) +++ +++ +++ ++ ++ ++ ++ ++ 
FA (20) ++ ++ + + + ++ ++ + 
FA (40) 0 + 0 0 0 + 0 0 
Note: 0: no abnormality detected, +: damage/ active changes up to less than 25 %, ++: damage/ active changes up to less than 50 %, +++: damage/ active changes up to less 75 %,  
++++: damage/ active changes up to more than 75 %  
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ethanol extract of bran (Rybka et al., 1993). 
Ferulic acid isolated by supercritical CO2 ex-
traction from ethanol Angelica sinensis 
(Oliv.) Diels extract showed potent antioxi-
dant potential (Sun et al., 2006). Further-
more, for extraction of phenolic compounds 
from various sources requires 80 % ethanol 
(Khoddami et al., 2013). Thus, in the present 
investigation, we have isolated a single com-
pound from the ethanol extract of P. cinerar-
ia. The physical and chemical methods were 
utilized to identify and determine the chemi-
cal structure of a single isolated compound 
from the ethanol extract of P. cineraria. 
Based on its physical properties and spec-
troscopic data (i.e., 1H NMR and 13C NMR), 
LC-MS, and IR, the isolated compound was 
characterized as ferulic acid, (4-hydroxy-3-
metoxybenzene acrylic acid), a phenolic 
compound with a molecular mass of 194.42 
daltons, and a molecular formula of 
C10H10O4 (Figure 2). The obtained spectral 
data were compared with the reported spec-
tral data by other research groups (Islam et 
al., 2008; Singh et al., 2013). On the basis of 
chemical characterization of FA, the isolated 
compound from the ethanol extract of P. 
cineraria, was confirmed as a single compo-
nent in pure form. Kumar and Pruthi (2014) 
found the highest known concentration of 
ferulic acid glucoside in flax seed (4.1 ± 
0.2 g/kg), however, in present investigation 
10.8 g/kg of ferulic acid (93 %) was isolated 
from the ethanol extract of P. cineraria. Fur-
thermore, we also evaluated the hypolipi-
demic potential of FA using the validated an-
imal model of High Fat Diet (HFD) induced 
hyperlipidemia in Sprague-Dawley rats. 
HMG-CoA reductase is an important en-
zyme in cholesterol biosynthesis and diet en-
riched with saturated fatty acids increases the 
activity of HMG-CoA reductase via in-
creased availability of acetyl-CoA. More-
over, high amount of cholesterol and saturat-
ed fatty acids associated with a down-
regulation of LDL receptors results in in-
creased serum LDL-C levels (Thirumalai et 
al., 2014). In HFD induced hyperlipidemia 
decreased in the activity of Lecithin Choles-
terol O-acyltransferase (LCAT) enzyme 
caused an alteration in the transesterification 
of cholesterol which in turn modulated the 
HDL-C activity (Ji et al., 2011). With in-
creased availability of free fatty acids, the 
triglyceride levels were significantly 
increased in HFD control group, which leads 
to decreased hepatic release of lipoprotein 
and increased esterification of free fatty ac-
ids (Thirumalai et al., 2014). VLDL particles 
are rich triglycerides and smaller than the 
chylomicrons. VLDL is the primary carrier 
of triglycerides. In the present investigation, 
there was a significant increase in the levels 
of TG, LDL-C and cholesterol level along 
with decreased in HDL-C level in serum as 
well as in liver. Administration of FA signif-
icantly inhibited this HFD-induced alteration 
in serum and liver lipid profile. In the pre-
sent study, serum VLDL levels were notably 
raised in HFD control group, whereas FA 
treatment significantly decreased the level of 
VLDL. Finding of our investigation is in line 
with the results of previous studies which 
showed that administration of reduced plas-
ma triglyceride, free fatty acid, and total cho-
lesterol in diabetic rats (Jin Son et al., 2010; 
Sri Balasubashini et al., 2003). Furthermore, 
FA has an ability to inhibit cholesterol syn-
thesis via competitive inhibition of HMG-
CoA reductase (Kim et al., 2003). Thus, this 
antihyperlipidemic potential of FA may be 
due to its ability to inhibit HMG-CoA reduc-
tase activity. 
In the pathogenesis of HFD-induced hy-
perlipidemia, increased cellular reactive 
oxygen species (ROS) played a vital role via 
increased oxidative stress thus decreasing 
antioxidant capacity. SOD and GSH are 
endogenous antioxidant enzymes which play 
an essential role in detoxification of toxic 
oxygen radicals (Kandhare et al., 2013a). 
SOD plays an important role in eliminating 
the superoxide radicals (Kandhare et al., 
2012b). GSH is a non-enzymatic biological 
antioxidant which plays a significant role in 
quenching of free radical species (such as 
hydrogen peroxide, superoxide and alkoxy 
radicals) act as a free radical scavenger 
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(Kandhare et al., 2014). There was a 
subsequent increase in lipid peroxidation 
(MDA) with increased production of free 
radicals which was evident from the reduc-
tion of antioxidant status of HFD control rats 
(Aydin, 2015; Kandhare et al., 2015). Ele-
vated MDA levels along with decreased lev-
els of GSH and SOD mirrors with the toxic 
effects of ROS produced by HFD, which is 
consistent with previously reported observa-
tions where HFD-administration caused a 
marked reduction in tissue antioxidant level 
(Aydin,. 2015). Whereas, administration of 
FA significantly inhibited HFD induced alter 
oxidative stress which may be due to its 
antioxidant potential. Findings of the present 
investigation are in line with results of the 
previous reports where treatment with FA 
improved liver antioxidant status (Bala-
subashini et al., 2004).  
It has been reported that elevated NO 
production played a vital role in the 
induction of various diseases including hy-
perlipidemia (Aydin, 2015). Tissue injury 
occurred when NO reacts with superoxide 
and forms peroxynitrites, and it is necessary 
to inhibit this NO production to ameliorate 
tissue injury (Kandhare et al., 2013b, 2012a). 
In the present investigation, HFD caused 
significant induction of liver damage via in-
crease in the production of NO. Administra-
tion of FA resulted in significant ameliora-
tion in HFD-induced elevated NO produc-
tion. It has been reported that FA modulated 
the nitric oxide (NO) bioavailability and de-
creased iNO synthesis (Suzuki et al., 2007). 
Our result provides credence to the finding 
of the previous researcher that FA caused in-
hibition of NO production. 
It has been reported that elevated oxida-
tive stress contributes to the development of 
atherosclerosis-linked metabolic syndrome 
(Choi et al., 2010). Moreover, high amounts 
of serum triglycerides are linked to athero-
sclerosis with increased risk of heart disease 
and stroke (Ong et al., 2009). HFD-induced 
hyperlipidemia is associated with altered an-
tioxidant defense mechanisms. Hypercholes-
terolemia leads to atherosclerosis and inhibi-
tion in lipid peroxidation inhibits this athero-
sclerosis (Yokozawa et al., 2003). In the pre-
sent investigation, rats administered with 
HFD exhibited an elevated level of oxidative 
stress along with LDL-C and triglycerides 
which in turn elevated atherosclerotic index. 
However, administration of FA produced a 
significant inhibition in atherosclerotic index 
via its antioxidative potential. Moreover, 
findings of previous research showed that 
phenolic compounds are effective in prevent-
ing the formation and progression of athero-
sclerosis which is mainly due to its antioxi-
dant and hypocholesterolemic potential 
(Carew et al., 1987). FA is a natural poly-
phenolic compound, possesses both antioxi-
dant and hypocholesterolemic activity and 
which might inhibit atherosclerosis progres-
sion. 
Atorvastatin is an effective agent with 
significant lipid-lowering potential widely 
used in the treatment of hyperlipidemia, ath-
erosclerosis or cardiovascular complications 
(such as coronary heart disease) (Stancu and 
Sima, 2001). It has an ability to inhibit 
HMG-CoA reductase enzyme, an enzyme 
which generates mevalonate via conversion 
from HMG-CoA. This inhibition of HMG-
CoA reductase enzyme serves as a rate-
limiting step in the biosynthesis of cholester-
ol. Thus, inhibition of HMG-CoA reductase, 
in turn, causes a reduction in cholesterol, 
LDL-cholesterol and total cholesterol levels 
(Davignon et al., 1992). However, they have 
the ability to reduce triglyceride concentra-
tions which depends on the baseline triglyc-
eride levels. However, in the present 
investigation, FA exhibited a significant re-
duction in total cholesterol and triglyceride 
in serum and also in hepatic tissue. 
In conclusion, the chemical structure of 
the isolated compound was determined by 1H 
NMR, 13C NMR and LC-MS experiment 
which revealed that only a single compound 
was isolated from an ethanol extract of P. 
cineraria and characterized as FA. Finally, 
the pure isolated FA was screened by using 
HFD-induced rat model for its hypolipidem-
ic action using serum and liver lipid parame-
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ters. FA (20 and 40 mg/kg) resulted in a 
significant reduction in TC, TG, LDL, 
VLDL-C, and a significant increase in HDL-
C in serum as well as hepatic tissue. It also 
resulted in a significant amelioration in he-
patic oxido-nitrosative stress induced by 
HFD. A recent study also showed that FA al-
leviates metabolic syndrome induced by 
high-carbohydrate diet in a rat model 
(Senaphan et al., 2015). Thus, it is concluded 
that ethanol extract of P. cineraria possessed 
hypolipidemic activity mainly due to FA via 
inhibition of elevated oxido-nitrosative 
stress. These results with pure isolated FA 
and previous results with ethanol extract of 
P. cineraria confirm that P. cineraria is ben-
eficial in preventing hyperlipidemia in labor-
atory animals. However, further study is in 
progress for the elucidation of actual mecha-
nism of action of FA isolated from P. cine-
raria at the molecular level. 
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